Effect of Individualized Training Versus Non-individualized Training to Improve Quality of Life of Sedentary Employees
Conditions: Exercise; Healthy Volunteers; Health; Quality of Life Interventions: Other: Performing following WHO (World Health Organization); Other: Performing on their needs Sponsor: Centre Hospitalier Universitaire de Saint Etienne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2021 Category: Research Source Type: clinical trials
Effect of Individualized Training Versus Non-individualized Training to Improve Quality of Life of Sedentary Employees
Conditions: Exercise; Healthy Volunteers; Health; Quality of Life Interventions: Other: Performing following WHO (World Health Organization); Other: Performing on their needs Sponsor: Centre Hospitalier Universitaire de Saint Etienne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2021 Category: Research Source Type: clinical trials
Johnson & Johnson Single-Shot COVID-19 Vaccine Granted Emergency Use Listing by the World Health Organization
NEW BRUNSWICK, N.J., March 12, 2021– Johnson& Johnson (NYSE: JNJ) (the Company) today announced that the World Health Organization (WHO) has issued Emergency Use Listing (EUL) for its single-shot COVID-19 vaccine, developed by the... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 12, 2021 Category: Pharmaceuticals Source Type: clinical trials
Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG – RAPID Trial): A structured summary of a study protocol for a randomised controlled trial
AbstractObjectivesTo determine the effect of therapeutic anticoagulation, with low molecular weight heparin (LMWH) or unfractionated heparin (UFH, high dose nomogram), compared to standard care in hospitalized patients admitted for COVID-19 with an elevated D-dimer on the composite outcome of intensive care unit (ICU) admission, non-invasive positive pressure ventilation, invasive mechanical ventilation or death up to 28 days.Trial designOpen-label, parallel, 1:1, phase 3, 2-arm randomized controlled trialParticipantsThe study population includes hospitalized adults admitted for COVID-19 prior to the development of critica...
Source: Trials - March 10, 2021 Category: Research Source Type: clinical trials
Dropouts in randomized clinical trials of Korean medicine interventions: a systematic review and meta-analysis
ConclusionsThis review found no significant difference in the dropout rate between studies according to the type of KM intervention. We recommend allowance for a minimum dropout rate of 15% in future RCTs of KM interventions.Review protocol registrationPROSPEROCRD42020141011 (Source: Trials)
Source: Trials - March 1, 2021 Category: Research Source Type: clinical trials
Johnson & Johnson Announces Submission to World Health Organization for Emergency Use Listing of Investigational Single-Shot Janssen COVID-19 Vaccine Candidate
NEW BRUNSWICK, N.J., February 19, 2021– Johnson& Johnson (NYSE: JNJ) (the Company) announced that Janssen-Cilag International N.V. has submitted for Emergency Use Listing (EUL) to the World Health Organization (WHO) for the... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 19, 2021 Category: Pharmaceuticals Source Type: clinical trials
Efficacy of the erector spinae plane (ESP) block for quality of recovery in posterior thoraco-lumbar spinal decompression surgery: study protocol for a randomised controlled trial
DiscussionTo the best of our knowledge, this will be the first randomised control trial to examine the efficacy and safety of the ESP block in terms of patient-centred outcomes in the setting of major spinal surgery. The QoR-15 is a validated means of assessing the quality of recovery after surgery and gives a more holistic assessment of the recovery experience from the patient ’s point of view.Trial registrationThis trial is pre-registered on ClinicalTrials.gov reference numberNCT04370951. Registered on 30 April 2020. All items from the World Health Organisation Trial Registration Data Set have been included. (Source: Trials)
Source: Trials - February 17, 2021 Category: Research Source Type: clinical trials
AstraZeneca COVID-19 Vaccine Authorised for Emergency Use by the World Health Organization
15 February 2021 -- AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunisation to prevent COVID-19 in individuals 18 years of age and older, including those over... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 15, 2021 Category: Pharmaceuticals Source Type: clinical trials
Accessibility of the World Health Organization's eTB Catalogue of Recommendations
Condition: Tuberculosis Interventions: Other: eTB Catalogue of Recommendations (eTB); Other: World Health Organization Tuberculosis Website (WHO TB) Sponsors: McMaster University; World Health Organization Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2021 Category: Research Source Type: clinical trials
